JPH0244549B2 - - Google Patents
Info
- Publication number
- JPH0244549B2 JPH0244549B2 JP62261651A JP26165187A JPH0244549B2 JP H0244549 B2 JPH0244549 B2 JP H0244549B2 JP 62261651 A JP62261651 A JP 62261651A JP 26165187 A JP26165187 A JP 26165187A JP H0244549 B2 JPH0244549 B2 JP H0244549B2
- Authority
- JP
- Japan
- Prior art keywords
- resin composition
- soft resin
- medical
- vinyl chloride
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000011342 resin composition Substances 0.000 claims description 64
- 239000008280 blood Substances 0.000 claims description 62
- 210000004369 blood Anatomy 0.000 claims description 61
- -1 monocarboxylic acid ester Chemical class 0.000 claims description 36
- 229920005989 resin Polymers 0.000 claims description 31
- 239000011347 resin Substances 0.000 claims description 31
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 23
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 22
- 229920002635 polyurethane Polymers 0.000 claims description 22
- 239000004814 polyurethane Substances 0.000 claims description 22
- 229920001577 copolymer Polymers 0.000 claims description 21
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 20
- 239000004014 plasticizer Substances 0.000 claims description 18
- 229920000573 polyethylene Polymers 0.000 claims description 13
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 12
- QAOJADINKLMTRR-UHFFFAOYSA-N octan-3-yl 16-methylheptadecanoate Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCCCCCCCC(C)C QAOJADINKLMTRR-UHFFFAOYSA-N 0.000 claims description 11
- OUCGJMIVSYHBEC-UHFFFAOYSA-N 2-ethylhexyl 2-ethylhexanoate Chemical compound CCCCC(CC)COC(=O)C(CC)CCCC OUCGJMIVSYHBEC-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 150000002430 hydrocarbons Chemical group 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 229920000728 polyester Polymers 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 7
- 229920002959 polymer blend Polymers 0.000 claims description 7
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 7
- 239000004800 polyvinyl chloride Substances 0.000 claims description 7
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 claims description 7
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 6
- 229920001169 thermoplastic Polymers 0.000 claims description 6
- 239000004416 thermosoftening plastic Substances 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 18
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 17
- 206010018910 Haemolysis Diseases 0.000 description 16
- 230000008588 hemolysis Effects 0.000 description 16
- 210000003743 erythrocyte Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 210000002381 plasma Anatomy 0.000 description 11
- 102000001554 Hemoglobins Human genes 0.000 description 8
- 108010054147 Hemoglobins Proteins 0.000 description 8
- 239000000306 component Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 4
- 210000004623 platelet-rich plasma Anatomy 0.000 description 4
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N Acetylene Chemical compound C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- KQSUNRSRSXGQTC-UHFFFAOYSA-N 2,2,8-trimethylnonanoic acid Chemical compound CC(C)CCCCCC(C)(C)C(O)=O KQSUNRSRSXGQTC-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- FOKDITTZHHDEHD-PFONDFGASA-N 2-ethylhexyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CC)CCCC FOKDITTZHHDEHD-PFONDFGASA-N 0.000 description 1
- DGGIWFWLKMKNQZ-UHFFFAOYSA-N 2-ethylhexyl 2,2-dimethylpropanoate Chemical compound CCCCC(CC)COC(=O)C(C)(C)C DGGIWFWLKMKNQZ-UHFFFAOYSA-N 0.000 description 1
- FTYSFPPFCAOKDQ-UHFFFAOYSA-N 2-ethylhexyl 2-methylpropanoate Chemical compound CCCCC(CC)COC(=O)C(C)C FTYSFPPFCAOKDQ-UHFFFAOYSA-N 0.000 description 1
- XEYIWOWYMLEPSD-UHFFFAOYSA-N 2-ethylhexyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(CC)CCCC XEYIWOWYMLEPSD-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- QRNFTMKPBPCPJO-UHFFFAOYSA-N 2-ethylhexyl hexanoate Chemical compound CCCCCC(=O)OCC(CC)CCCC QRNFTMKPBPCPJO-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- FSJUXYZQJUNUBZ-UHFFFAOYSA-N 2-ethylhexyl pentanoate Chemical compound CCCCC(CC)COC(=O)CCCC FSJUXYZQJUNUBZ-UHFFFAOYSA-N 0.000 description 1
- GRXOKLJPWSYWIA-UHFFFAOYSA-N 2-ethylhexyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CC)CCCC GRXOKLJPWSYWIA-UHFFFAOYSA-N 0.000 description 1
- GXJLQJFVFMCVHG-QXMHVHEDSA-N 2-methylpropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)C GXJLQJFVFMCVHG-QXMHVHEDSA-N 0.000 description 1
- FPBZIVPZCGICNQ-UHFFFAOYSA-N 2-methylpropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)C FPBZIVPZCGICNQ-UHFFFAOYSA-N 0.000 description 1
- SZFOMJOELAAHAF-UHFFFAOYSA-N 2-methylpropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)C SZFOMJOELAAHAF-UHFFFAOYSA-N 0.000 description 1
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 description 1
- SKVCWXRLKHBEKW-UHFFFAOYSA-N 2-methylpropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(C)C SKVCWXRLKHBEKW-UHFFFAOYSA-N 0.000 description 1
- XWHWKWUYOUQUQQ-UHFFFAOYSA-N 3-methylbutyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCCC(C)C XWHWKWUYOUQUQQ-UHFFFAOYSA-N 0.000 description 1
- XVSZRAWFCDHCBP-UHFFFAOYSA-N 3-methylbutyl hexanoate Chemical compound CCCCCC(=O)OCCC(C)C XVSZRAWFCDHCBP-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IZVWMVLDHOGHMJ-UHFFFAOYSA-N 4-methylpentyl hexanoate Chemical compound CCCCCC(=O)OCCCC(C)C IZVWMVLDHOGHMJ-UHFFFAOYSA-N 0.000 description 1
- LMECUOUDHGZDGT-UHFFFAOYSA-N 5-methylhexyl pentanoate Chemical compound C(CCCC)(=O)OCCCCC(C)C LMECUOUDHGZDGT-UHFFFAOYSA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- 102000007347 Apyrase Human genes 0.000 description 1
- 108010007730 Apyrase Proteins 0.000 description 1
- 101710131215 Apyrase 2 Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920003314 Elvaloy® Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- PKPPDYGHKDIKBH-UHFFFAOYSA-N Isopropyl dodecanoic acid Chemical compound CCCCCCCCCC(=O)OC(C)C PKPPDYGHKDIKBH-UHFFFAOYSA-N 0.000 description 1
- 229920001944 Plastisol Polymers 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical group CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010101 extrusion blow moulding Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- AXTPGRJJIGEOOY-UHFFFAOYSA-N isobutyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)C AXTPGRJJIGEOOY-UHFFFAOYSA-N 0.000 description 1
- 229940037626 isobutyl stearate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- CPXCDEMFNPKOEF-UHFFFAOYSA-N methyl 3-methylbenzoate Chemical compound COC(=O)C1=CC=CC(C)=C1 CPXCDEMFNPKOEF-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000004999 plastisol Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003634 thrombocyte concentrate Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Materials For Medical Uses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62261651A JPH01104269A (ja) | 1987-10-19 | 1987-10-19 | 医療用軟質樹脂組成物および医療用具 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62261651A JPH01104269A (ja) | 1987-10-19 | 1987-10-19 | 医療用軟質樹脂組成物および医療用具 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01104269A JPH01104269A (ja) | 1989-04-21 |
| JPH0244549B2 true JPH0244549B2 (pt) | 1990-10-04 |
Family
ID=17364868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62261651A Granted JPH01104269A (ja) | 1987-10-19 | 1987-10-19 | 医療用軟質樹脂組成物および医療用具 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01104269A (pt) |
-
1987
- 1987-10-19 JP JP62261651A patent/JPH01104269A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01104269A (ja) | 1989-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0396724B1 (en) | Plastic composition with anti-hemolytic effect | |
| EP0537863B1 (en) | Use of a triglyceride compound as a hemolysis depressant | |
| EP0230744B1 (en) | Propylene polymer composition | |
| US5167657A (en) | Plastic composition with anti-hemolytic effect | |
| WO1993014810A2 (en) | Material for medical grade products and products made therefrom | |
| US5248531A (en) | Hemolysis depressant and plasticizer | |
| US6468258B1 (en) | Plastic compositions including vitamin E for medical containers and methods for providing such compositions and containers | |
| EP0054221B1 (en) | Multiple blood bag system made of plastic substantially free of blood extractible plasticizers | |
| EP0409155B1 (en) | Bag for storage of platelets and multiple bag system containing the bag | |
| AU623071B2 (en) | Hemolysis inhibitor and medical resin composition, medical implement, and blood-preserving fluid containing the same | |
| JPH0244549B2 (pt) | ||
| JPH0244550B2 (pt) | ||
| JPH0242504B2 (pt) | ||
| JPH0242502B2 (pt) | ||
| EP0108955B1 (en) | Medical articles | |
| JPH01164372A (ja) | 溶血抑制剤およびこれを配合してなる医療用具 | |
| JPH0242501B2 (pt) | ||
| JPH0999036A (ja) | 医療用容器 | |
| CA1306698C (en) | Hemolysis depressant, and medical resin composition, medical implement and blood preserving liquid using the hemolysis depressant | |
| JPH01104265A (ja) | 医療用軟質塩化ビニル系樹脂組成物および医療用具 | |
| JPH0521090B2 (pt) | ||
| JPH01104267A (ja) | 医療用軟質塩化ビニル系樹脂組成物および医療用具 | |
| JPH0242507B2 (pt) | ||
| JPS6158192B2 (pt) | ||
| JPH04320840A (ja) | 複合フィルム |